BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/11/2016 11:41:00 AM | Browse: 492 | Download: 406
Publication Name World Journal of Diabetes
Manuscript ID 24895
Country/Territory India
2016-02-14 10:02
Peer-Review Started
2016-02-16 14:46
To Make the First Decision
2016-03-23 10:37
Return for Revision
2016-03-25 17:16
2016-05-16 18:01
Second Decision
2016-07-28 14:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-08-10 11:52
Articles in Press
2016-08-10 11:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-09-27 15:49
Publish the Manuscript Online
2016-10-11 11:41
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology and Metabolism
Manuscript Type Minireviews
Article Title Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome
Manuscript Source Invited Manuscript
All Author List Sanjay Chatterjee, Samit Ghosal and Saurav Chatterjee
Funding Agency and Grant Number
Corresponding author Sanjay Chatterjee, MD, Consultant Diabetologist, Apollo Gleneagles Hospital, 58 Canal Circular Road, Kolkata 700054, India. sanjay_doc@yahoo.co.in
Keywords Metabolic syndrome; Diabetes; Glucagon-like peptide-1 receptor agonists; Lipids; Body weight; Microalbuminuria
Core Tip The incidence of metabolic syndrome (MetS) is on the rise globally. This will have a negative impact on cardiovascular outcome. Whereas most of the anti-hyperglycemic agents have neutral or negative effects on components of MetS, glucagon-like peptide-1 receptor agonists drugs favorably address all components of MetS. By doing so, they may have a cardio protective role. We have reviewed recent literature to give an updated account on the topic. Results from recently concluded clinical trials suggest that some of the molecules in this class may have favor-able effects on cardiovascular outcome.
Publish Date 2016-10-11 11:41
Citation Chatterjee S, Ghosal S, Chatterjee S. Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome. World J Diabetes 2016; 7(18): 441-448
Url http://www.wjgnet.com/1948-9358/full/v7/i18/441.htm
DOI http://dx.doi.org/10.4239/wjd.v7.i18.441
Full Article (PDF) WJD-7-441.pdf
Full Article (Word) WJD-7-441.doc
Manuscript File 24895-Review.doc
Answering Reviewers 24895-Answering reviewers.pdf
Audio Core Tip 24895-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 24895-Conflict-of-interest statement.pdf
Copyright License Agreement 24895-Copyright assignment.pdf
Peer-review Report 24895-Peer-review(s).pdf
Scientific Misconduct Check 24895-Scientific misconduct check.pdf
Scientific Editor Work List 24895-Scientific editor work list.pdf